Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D002176:Candida albicans / Q000276:immunology; D002179:Candidiasis, Cutaneous / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007111:Immunity, Cellular; D037102:Lectins; D007962:Leukocytes / Q000378:metabolism; D008214:Lymphocytes; D008938:Mitosis; D012882:Skin Tests; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D037102:Lectins; D014316:Tritium; D000666:Amphotericin B; D013936:Thymidine